Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
55,351,475
-
Total 13F shares
-
51,091,479
-
Share change
-
+875,383
-
Total reported value
-
$286,110,760
-
Put/Call ratio
-
66%
-
Price per share
-
$5.60
-
Number of holders
-
56
-
Value change
-
+$4,782,079
-
Number of buys
-
31
-
Number of sells
-
27
Institutional Holders of Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) as of Q2 2023
As of 30 Jun 2023,
Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,091,479 shares.
The largest 10 holders included
Flagship Pioneering Inc., FMR LLC, HarbourVest Partners LLC, Artal Group S.A., STATE OF WISCONSIN INVESTMENT BOARD, BlackRock Inc., VANGUARD GROUP INC, CHI Advisors LLC, PLATINUM INVESTMENT MANAGEMENT LTD, and 683 Capital Management, LLC.
This page lists
56
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.